Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps

Abstract Molecular Tumor Boards (MTBs) are pivotal in personalized cancer care. This systematic review and meta-analysis included 34 studies out of 576 articles (2020–January 2024) involving 12,176 patients across 26 major cancer entities. Of these, 20.8% (2,532 patients) received MTB-recommended th...

Full description

Saved in:
Bibliographic Details
Main Authors: Beryl Primrose Gladstone, Janina Beha, Arisa Hakariya, Pavlos Missios, Nisar P. Malek, Michael Bitzer
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-025-00865-1
Tags: Add Tag
No Tags, Be the first to tag this record!